Detection of residual E. coli and CHOhost-cellDNA in recombinant proteins by qPCR

Production of recombinant proteins is a steadily growing industry in Russia and all over the world. Both producer and substance should be properly characterized and tested against all safety criteria. One of the mandatory requirements to the mentioned drugs is the assessment of the content of residual DNA-producing cells, which should be less than 10 ng per dose. There are not many commercial kits for detection of residual DNA and they are based on four different methods. The article provides a brief overview of these methods and highlights their advantages and disadvantages. Common disadvantage of all the commercial kits is their price. The main goal of the research was to choose an optimal method of DNA extraction from protein substances and samples of various protein purification steps, as well as to work over measuring the amount of residual E. coli DNA and CHO by qPCR method not using commercial kits. The article also provides with a number of practical recommendations on specific aspects of DNA extraction and reference standard storage. The aim of the study was to find a reliable and inexpensive method for determining residual DNA-producing cells in recombinant protein samples. The article provides with an overview of DNA extraction methods, stipulates the necessity of DNA extraction prior to the analysis. The advantage was given to the method of spin-column extraction. Optimal DNA extraction method for its assay in a substance is the method, which provides with a stable DNA yield, including different chemical structure of the samples, and upon the condition that no protein and other impurities are detected in the isolated DNA solution. The proposed method for DNA spin-column extraction is the least labor-intensive, is optimized for DNA isolation from protein substances and samples of various protein purification steps. Self preparation of solutions for DNA extraction is a simple procedure and can reduce analysis costs. The report on successful adaptation of the methods of residual E. coli and CHO DNA detection by qPCR using fluorescent probes was provided. The sensitivity of the method was demonstrated at least 1 pg/ml for the analysis of the amount of residual DNA both for E. coli and CHO.

определение остаточной ДНК клеток-продуцентов, остаточная ДНК клеток хозяина, qPCR ДНК CHO, qPCR ДНК E. coli, выделение ДНК из субстанций рекомбинантных белков, detection of residual DNA-producing cells, residual host-cell DNA, the DNA qPCR CHO host cell, qPCR E. coli host-cell DNA, DNA isolation from protein solutions

1. Andersen DC, Krummen L. Recombinant protein expression for therapeutic applications. Curr Opin Biotechnol. 2002; 13: 117–23.

2. Mironov AN, Merkulov VA, Sakaeva VI, Vasiliev AN, Bunyatyan ND, Kukes VG, et al. Evaluation of the quality of biological drugs derived using recombinant DNA techniques. In: Guidelines for the examination of medicines. V. 3. Moscow: POLIGRAF-PLUS; 2014. P. 4–24 (in Russian).

3. Note for Guidance on Production and Quality Control of Medicinal Products Derived by Recombinant DNA Technology, 3AB1A. Production and Quality Control of Medicinal Products derived by recombinant DNA Technology. 1995. P. 214.

4. WHO. WHO Expert Committee on Biological standardization: Highlights of the 46th meeting, October 1996. WHO Wkly Epidemiol. Rec. 72, 1997, pp. 141–5.

5. Lahijani M, Duhon M, Lusby E, Betita H, Marquet M. Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive PCR and enzyme linked immunosorbent assay. Hum Gene Ther. 1988; (9): 1173–80.

6. Wang X, Morgan DM, Wang G, Mozier NM. Residual DNA Analysis in Biologics Development: Review of Measurement and Quantitation Technologies and Future Directions. Biotechnology&Bioengeneering. Published online 28 September 2011 in Wiley Online Library (wileyonlinelibrary.com). doi 10.1002/bit.23343.

7. Points to consider in the manufacture and testing of monoclonal antibody products for human use. US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, U. S. A. FDA; 1997.

8. Position statement on the use of tumourigenic cells of human origin for the production of biological and biotechnological medicinal products. Biotechnology Working Party, Committee for Proprietary Medicinal Product, The European Agency for the Evaluation of Medicinal Products: Evaluation of Medicinal Products for Human Use, EU. CPMP; 2001.

9. Medicines produced using recombinant DNA techniques. General monograph 1.7.1.0007.15. The State Pharmacopoeia of the Russian Federation. 13th edition. V. 2. P. 536–7. Moscow; 2015. Available from: http://femb.ru/feml.

10. WHO Expert Committee on Biological Standardization, World Health Organ. Teth. Rep. Ser. 1998; 878: 1–101.

11. Lee DH, Bae JE, Lee JH, Shin JS, Kim IS. Quantitative detection of residual E. coli host cell DNA by real-time PCR. J Microbiol Biotechnol. 2010; 20(10): 1463–70.

12. Kung VT, Panfili PR, Sheldon EL, King RS, Nagainis PA, Gomez JB, et al. Picogram quantitation of total DNA using DNA-binding proteins in a silicon sensor-based system. Anal Biochem. 1990; 187: 220–7.

13. Vaneechoutte M, Van Eldere J. The possibilities and limitations of nucleic acid amplification technology in diagnostic microbiology. J Med Microbiol. 1997; 46: 188–94.

14. Abu Al-Soud W, Jönsson LJ, Rådström P. Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR. J Clin Microbiol. 2000; 38: 345–50.

15. Abu Al-Soud W, Rådström P. Purification and Characterization of PCR-Inhibitory Components in Blood Cells. J Clin Microbiol. 2001; 39(2): 485–93.

16. Peper G, Fankhauser A, Merlin T, Roscic A, Hofmann M, Obrdlik P. Direct real-time quantitative PCR for measurement of host-cell residual DNA in therapeutic proteins. J Pharm Biomed Anal 2014; 100: 123–30.

17. Goldenberger D, Perschil I, Ritzler M, Altwegg M. A simple «universal» DNA extraction procedure using SDS and proteinase K is compatible with direct PCR amplification. PCR Methods Appl. 1995; (4): 368–70.

18. Hussain M. A direct qPCR method for residual DNA quantification in monoclonal antibody drugs produced in CHO cells. J Pharm Biomed Anal. 2015; 115: 603–6.

19. Hu B, Sellers J, Kupeca J, Ngob W, Fentona S, Yanga TY, Grebaniera A. Optimization and validation of DNA extraction and real-time PCR assay for the quantitative measurement of residual host cell DNA in biopharmaceutical products. J Pharm Biomed Anal. 2014; 88: 92–5.

20. Vogelstein B, Gillespie D. Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci. USA 1979; 76: 615–9.

21. Zhang W, Wu M, Menesale E, Lu T, Magliola A, Bergelson S. Development and qualification of a high sensitivity, high throughput Q-PCR assay for quantitation of residual host cell DNA in purification process intermediate and drug substance samples. J Pharm Biomed Anal. 2014; 100: 145–9.

22. Venable D, Miro-Quesada G, Calley J, Monson E, He L. High-throughput and quantitative detection of residual NS0 and CHO host cell genomic DNA. BioProcess Int. 2007; (5): 56–61.

23. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; (3): 495–503.

24. Siddappa NB, Avinash A, Venkatramanan M, Ranga U. Regeneration of commercial nucleic acid extraction columns without the risk of carryover contamination. BioTechniques 2007; 42: 186–92.

25. Röder B, Frühwirth K, Vogl C, Wagner M, Rossmanith P. Impact of long-term storage on stability of standard DNA for nucleic acid-based methods. J Clin Microbiol. 2010; 48(11): 4260–2.

26. Glasel JA. Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. BioTechniques 1995; 18: 62–6.

27. Podivinsky E, Love JL, van der Colff L, Samuel L. Effect of storage regime on the stability of DNA used as a calibration standard for real-time polymerase chain reaction. Anal Biochem. 2009; 394(1): 132–4.

28. Smith S, Morin P. Optimal storage conditions for highly dilute DNA samples: a role for trehalose as a preserving agent. J Forensic Sci. 2006; 51(2): 426–32.

29. Haynes SR, Toomey TP, Leinwand L, Jelinek WR. The Chinese hamster Alu-equivalent sequence: a conserved highly repetitious, interspersed deoxyribonucleic acid sequence in mammals has a structure suggestive of a transposable element. Molecular Cellular Biology 1981; 1(7): 573–83.

30. Verardo ML, Carvalho JG, Delgado DN, Kuhns ST. Accuracy and sensitivity of residual DNA detection by qPCR is not predicted by target copy number. Biotechnology Progress 2012; 28(2): 428–34.

31. Brosius J, Dull TJ, Sleeter DD, Noller HF. Gene organization and primary structure of a ribosomal RNA operon from Escherichia coli. J Bacteriol. 1981; 62: 293–300.

32. Farivar TN, Mamnoon B, Arzenani MK, Ilghari D. Novel real time polymerase chain reaction approach for rapid detection of the residual Escherichia coli genomic DNA in biopharmaceutical products establishment of real time polymerase chain reaction to detect residual gDNA. Biotech Health Sci. 2014; 3(1): 263–75.

33. Silkie SS, Tolcher MP, Nelson KL. Reagent decontamination to eliminate false-positives in Escherichia coli qPCR. J Microbiol Meth. 2008; 72: 275–82.

34. Kibbee R, Linklater N, Örmeci B. Eliminating false positives in a qPCR assay for the detection of the uidA gene in Escherichia coli. J Water Health 2013; 11(3): 382–6.